MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$500,224K
Short-term investments
$216,981K
Prepaid expenses and
other current assets
$12,959K
Total current assets
$730,164K
Other non-current
assets
$15,060K
Long-term investments
$1,340K
Operating lease
right-of-use assets, net
$1,090K
Property and equipment,
net
$28K
Total assets
$747,682K
Total liabilities and
stockholders' equity
$747,682K
Total liabilities
$411,853K
Total stockholders'
equity
$335,829K
Accumulated deficit
-$846,115K
Accumulated other
comprehensive loss
-$377K
Total long-term
liabilities
$350,692K
Total current
liabilities
$61,161K
Additional paid-in capital
$1,182,315K
Common stock, par value
0.0001 per share...
$6K
Convertible senior notes,
net
$193,631K
Royalty obligation
$84,900K
Senior secured term
loan, net
$72,084K
Operating lease
liabilities, less current...
$77K
Accrued expenses
$51,180K
Accounts payable
$8,944K
Operating lease
liabilities, current
$1,037K
Back
Back
Balance Sheet
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)
source: myfinsight.com